Insulin and Sarcopenia in the Elderly

Completed · Phase 1

Conditions studied: Sarcopenia

In brief

Muscle loss with aging is a significant contributor to disability in older people. Our general hypothesis is that loss of muscle with aging, known as sarcopenia, may be due to inability of muscle to grow in response to insulin. Our goal is to determine the mechanisms underlying this age-related insulin resistance of muscle proteins, which will allow us to define in the future specific interventions to target this defect and provide the scientific basis for the prevention and treatment of sarcopenia.

Key facts

Study ID
NCT00690534
Run by
The University of Texas Medical Branch, Galveston
People needed
88
Starts
2005-09-01
Expected to finish
2012-08-01
Last updated by the study team
2016-12-12

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.